Evaluation of a Wearable Device for Acute Treatment of Migraines

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 9, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
MigraineMigraine With or Without AuraMigraine, AcuteMigraine Headache
Interventions
DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS)

Use of TENS device for 1 hour during each migraine episode.

Trial Locations (1)

94105

RECRUITING

Hinge Health, Inc., San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hinge Health, Inc

INDUSTRY

NCT07015125 - Evaluation of a Wearable Device for Acute Treatment of Migraines | Biotech Hunter | Biotech Hunter